Udenyca

A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
Investors Business Daily
Sat, 10/5/19 - 02:17 pm
Coherus Biosciences
Novartis
Udenyca
Neulasta
biosmilars
Coherus' Neulasta biosimilar surprises with strong early uptake
Biopharma Dive
Mon, 04/8/19 - 05:44 pm
Coherus Biosciences
Neulasta
biosimilars
Udenyca
Amgen